Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 2Completed 1

Sponsor Class

OTHER 155INDUSTRY 10NIH 8NETWORK 4OTHER_GOV 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 1Liver Neoplasms 1Hepatitis B 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Radiofrequency Ablation × Clear all
NCT05162898 2022-01-27

Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.

Henan Cancer Hospital

Phase NA Unknown
90 enrolled
Gastrointestinal

Liver Neoplasms

NCT03166436 2017-05-30

RFA for Malignant Biliary Obstruction

Institute for Clinical and Experimental Medicine

Phase NA Unknown
140 enrolled
Gastrointestinal

Pancreatic Neoplasms, Cholangiocarcinoma

NCT01018381 2009-11-23

Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection

The 108 Military Central Hospital

Phase NA Completed
130 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡